Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular Dementia

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188

Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*

Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314

Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Biedler, J. L., Helson, L., & Spengler, B. A. (1973) · PubMed · Cited by 1,295

Production of hybridoma growth factor by human monocytes

Aarden, L. A., de Groot, E. R., Schaap, O. L., & Lansdorp, P. M. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171004 · Cited by 1,091

Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia

Martinou, J., Dubois‐Dauphin, M., Staple, J. K., Rodríguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., & Pietra, C. (1994) · Neuron · doi:10.1016/0896-6273(94)90266-6 · Cited by 1,087

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,029

Tau in Alzheimer's disease

Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 980

A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen

Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 845

Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease

Tobinick, E. L. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015073 · Cited by 34

Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood

Lönneborg, A. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256296 · Cited by 33

Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: A pilot study

Lee, M. H., Park, D., Back, D.-B., Lee, J.-Y., Lee, C.-I., Park, K.-J., Kang, S.-H., Cho, T.-H., & Chung, Y.-G. (2012) · Medical Science Monitor · doi:10.12659/msm.883586 · Cited by 30

Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets

Osera, C., Pascale, A., Amadio, M., Venturini, L., Govoni, S. M., & Ricevuti, G. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.004 · Cited by 30

Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases

Noelker, C., Hampel, H. J., & Dodel, R. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256398 · Cited by 29

Variants of Base Excision Repair Genes MUTYH, PARP1 and XRCC1 in Alzheimer's Disease Risk

Kwiatkowski, D., Czarny, P. L., Gałecki, P., Bachurska, A., Talarowska, M. E., Orzechowska, A., Bobińska, K., Bielecka-Kowalska, A., Pietras, T., Szemraj, J., et al. (2015) · Neuropsychobiology · doi:10.1159/000381985 · Cited by 29

Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection

Safieh‐Garabedian, B., Ochoa‐Chaar, C. I., Poole, S., Massaad, C. A., Atweh, S., Jabbur, S. J., & Saadé, N. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00500-1 · Cited by 29

Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia

Mulugeta, E., Molina‐Holgado, F., Elliott, M. S. J., Hortobágyi, T., Perry, R., Kalaria, R. N., Ballard, C. G., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000118633 · Cited by 29

Intereleukin-10 Promoter Polymorphism in Mild Cognitive Impairment and in Its Clinical Evolution

Arosio, B., Mastronardi, L., Vergani, C., & Annoni, G. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/854527 · Cited by 29

Associations Between Serum Inflammatory Markers and Hippocampal Volume in a Community Sample

Schmidt, M. F., Freeman, K. B., Windham, B. G., Griswold, M. E., Kullo, I. J., Turner, S. T., & Mosley, T. H. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14283 · Cited by 28

Cardiovascular Dementia - A Different Perspective

Kumari, U., & Heese, K. (2010) · The Open Biochemistry Journal · doi:10.2174/1874091x01004010029 · Cited by 27

Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes

Lee, C., Low, C. Y. B., Wong, S. Y., Lai, M. K. P., & Tan, M. G. K. (2017) · Scientific Reports · doi:10.1038/srep43651 · Cited by 27

Hydroxychavicol inhibits immune responses to mitigate cognitive dysfunction in rats

Pandey, A., & Bani, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.031 · Cited by 27

TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF

Calsavara, A. J. C., Soriani, F. M., Vieira, L. Q., Costa, P. A., Rachid, M. A., & Teixiera, A. L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9610-8 · Cited by 26

The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

Anuradha, U., Kumar, A., & Singh, R. K. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05343-7 · Cited by 24

Diabetic encephalopathy: the role of oxidative stress and inflammation in type 2 diabetes

Reis, F., Soares, Nunes, & Pereira, F. C. (2012) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s29322 · Cited by 26

Heat Shock Protein 70 and Tumor Necrosis Factor Alpha in Taiwanese Patients with Dementia

Fung, H., Chen, C. M., Wu, Y.-Y., Hsu, W.-W., Ro, L. ‐., Lin, J., Chang, K. H., Wang, H., Lin, S., Chan, H.-L., et al. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000085067 · Cited by 24

Insight into the Molecular Imaging of Alzheimer’s Disease

Arora, A., & Bhagat, N. (2016) · International Journal of Biomedical Imaging · doi:10.1155/2016/7462014 · Cited by 23

Intrathecal Release of Nitric Oxide in Alzheimer’s Disease and Vascular Dementia

Tarkowski, E., Ringqvist, Å., Blennow, K., Wallin, A., & Wennmalm, Å. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017261 · Cited by 23

Characterisation of amyloid-induced inflammatory responses in the rat retina

Howlett, D. R., Bate, S. T., Collier, S., Lawman, A. J., Chapman, T. D., Ashmeade, T. E., Marshall, I. C. B., Anderson, P. J., Philpott, K. L., Richardson, J. C., et al. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2819-4 · Cited by 22

ACAT1/SOAT1 Blockade Suppresses LPS-Mediated Neuroinflammation by Modulating the Fate of Toll-like Receptor 4 in Microglia

Li, H., Huynh, T. N. T., Duong, M. T., Gow, J. G., Chang, C. C. Y., & Chang, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065616 · Cited by 19

The "Alzheimer's disease signature": potential perspectives for novel biomarkers

Davinelli, S., Intrieri, M., Russo, C., Costanzo, A. D., Zella, D., Bosco, P., & Scapagnini, G. (2011) · Immunity & Ageing · doi:10.1186/1742-4933-8-7 · Cited by 22

Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer’s Disease: A Narrative Review

Puga, A. M., Ruperto, M., Samaniego-Vaesken, M. D. L., Montero-Bravo, A., Partearroyo, T., & Varela‐Moreiras, G. (2021) · Nutrients · doi:10.3390/nu13092966 · Cited by 23

Immunological Aspects of Alzheimer??s Disease

Hoozemans, J. J. M., Rozemüller, A. J. M., Veerhuis, R., & Eikelenboom, P. (2001) · BioDrugs · doi:10.2165/00063030-200115050-00004 · Cited by 21

CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation

Pulliam, L., Irwin, I., Kusdra, L., Rempel, H. C., Flitter, W. D., & Garland, W. A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03293-5 · Cited by 21

Erratum to: TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF

Calsavara, A. J. C., Soriani, F. M., Vieira, L. Q., Costa, P. A., Rachid, M. A., & Teixeira, A. L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9620-6 · Cited by 21

Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease

Ou-Yang, P., Cai, Z., & Zhang, Z.-H. (2023) · Aging and Disease · doi:10.14336/ad.2023.0106 · Cited by 21

Alzheimer’s Disease Patients Display Gender Dimorphism in Circulating Anorectic Adipokines

Intebi, A. D., Garau, L., Brusco, I., Pagano, M. A., Gaillard, R. C., & Spinedi, E. (2002) · NeuroImmunoModulation · doi:10.1159/000071476 · Cited by 20

Adenosine A2A Receptor and IL‐10 in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment

Arosio, B., Mastronardi, L., Gussago, C., Nicolini, P., Casè, A., Ziglioli, E., & Bergamaschini, L. C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/484021 · Cited by 20

Weight loss in Alzheimer's disease, vascular dementia and dementia with Lewy bodies: Impact on mortality and hospitalization by dementia subtype

Soysal, P., Tan, S. G., Rogowska, M., Jawad, S., Smith, L., Veronese, N., Tsiptsios, D., Tsamakis, K., Stewart, R. J., & Mueller, C. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5659 · Cited by 18

Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease

Salai, K. H. T., Wu, L., Chong, J. R., Chai, Y. L., Gyanwali, B., Robert, C., Hilal, S., Venketasubramanian, N., Dawe, G. S., Chen, C., et al. (2023) · Biomolecules · doi:10.3390/biom13030525 · Cited by 20

Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?

Bhamra, M. S., & Ashton, N. J. (2012) · Electrophoresis · doi:10.1002/elps.201200161 · Cited by 21

Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities

Luo, W., Tweedie, D., Beedie, S., Vargesson, N., Figg, W. D., Greig, N. H., & Scerba, M. T. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.032 · Cited by 18

Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases

Clapcote, S. J. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-58811-7_5 · Cited by 18

Heparan sulfate proteoglycan induces the production of NO and TNF-α by murine microglia

Bussini, S., Meda, L., Scarpini, E. A., Clementi, E., Conti, G. M., Tiriticco, M., Bresolin, N., & Baron, P. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-11 · Cited by 17

Biomarkers of Alzheimer disease in plasma

Irizarry, M. C. (2004) · Neurotherapeutics · doi:10.1007/bf03206606 · Cited by 17

Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer’s disease mice

Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05008-x · Cited by 19

Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease

Lauterbach, E. C. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318214b7d0 · Cited by 15

Effect of Sertoli Cell Transplantation on Reducing Neuroinflammation-Induced Necroptosis and Improving Motor Coordination in the Rat Model of Cerebellar Ataxia Induced by 3-Acetylpyridine

Saeidikhoo, S., Ezi, S., Khatmi, A., Aghajanpour, F., Soltani, R., Abdollahifar, M., Jahanian, A., & Aliaghaei, A. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01522-x · Cited by 16

Serum BDNF, TNF- α and IL-1β levels in dementia patients

Yasutake, C. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0702-2 · Cited by 16

The protective effects and mechanisms of Polygonatum sibiricum polysaccharides in chronic stress-induced neural damage

Zhang, X., Wang, D., Liu, Y., Sun, J., Fan, B., Wang, F., & Lü, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120219 · Cited by 15

Circulating inflammatory cytokine levels correlates with cognitive impairment

Marzabadi, L. R., Sadigh‐Eteghad, S., & Talebi, M. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12613 · Cited by 15

Novel inflammatory markers associated with cognitive performance: Singapore Longitudinal Ageing Studies

Gao, Q., Camous, X., Lu, Y., Lim, M.-L., Larbi, A., & Ng, T. P. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.002 · Cited by 15

Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+are linked to differences in plasma carotenoid concentrations

Guest, J., Grant, R., Garg, M. L., Mori, T. A., Croft, K. D., & BILGIN, A. A. B. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-117 · Cited by 15

Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways

Schlatterer, S. D., Suh, H.-S., Conejero‐Goldberg, C., Chen, S., Acker, C. M., Lee, S. C., & Davies, P. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-208 · Cited by 15

Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia

Gao, H., Findeis, E. L., Culmone, L., Powell, B., Landschoot‐Ward, J., Zacharek, A., Wu, T., Lü, M., Chopp, M., & Venkat, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1180913 · Cited by 13

Combining Select Neuropsychological Assessment with Blood-Based Biomarkers to Detect Mild Alzheimer's Disease: A Molecular Neuropsychology Approach

Edwards, M., Balldin, V. H., Hall, J. R., & O’Bryant, S. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140852 · Cited by 14

CanToxoplasma gondiiPave the Road for Dementia?

Saftawy, E. A. E., Amin, N. M. A., Sabry, R. M., El‐Anwar, N., Shash, R. Y., Elsebaie, E. H., & Wassef, R. M. (2020) · Journal of Parasitology Research · doi:10.1155/2020/8859857 · Cited by 13

Handgrip strength, tumor necrosis factor-α, interlukin-6, and visfatin levels in oldest elderly patients with cognitive impairment

Huang, H., Chang, J. C., Liu, H.-C., Yang, Z.-Y., Yang, Y.-J., Chen, L., & Yen, D. H.-T. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111138 · Cited by 12

Recent advances in pre-clinical diagnosis of Alzheimer’s disease

Zhou, J., Benoit, M., & Sharoar, M. G. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00733-4 · Cited by 14

The role of −850 tumor necrosis factor-α and apolipoprotein E genetic polymorphism in patients with Down's syndrome-related dementia

Lucarelli, P., Piciullo, A., Verdecchia, M., Palmarino, M., Arpino, C., & Curatolo, P. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.021 · Cited by 11

Alpha1-antichymotrypsin induces TNF-α production and NF-κB activation in the murine N9 microglial cell line

Braghin, E., Galimberti, D., Scarpini, E. A., Bresolin, N., & Baron, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.057 · Cited by 11

Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease

Fiolaki, A., Tsamis, K. I., Milionis, H. J., Kyritsis, A. P., Kosmidou, M. S., & Giannopoulos, S. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.821988 · Cited by 11

Serum-Derived Immunoglobulins Neutralize Adverse Effects of Amyloid-β Peptide on the Integrity of a Blood-Brain Barrier In Vitro Model

Poetsch, V., Neuhaus, W., & Noe, C. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090769 · Cited by 11

In a circuit necessary for cognition and emotional affect, Alzheimer's-like pathology associates with neuroinflammation, cognitive and motivational deficits in the young adult TgF344-AD rat

Hernandez, C. M., McCuiston, M. A., Davis, K., Halls, Y., Zotto, J. P. C. D., Jackson, N. L., Dobrunz, L. E., King, P. H., & McMahon, L. L. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100798 · Cited by 11

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers

Sasayama, D., Hattori, K., Yokota, Y., Matsumura, R., Teraishi, T., Yoshida, S., & Kunugi, H. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12110 · Cited by 9

Impaired regulation of immune responses in cognitive decline and Alzheimer’s disease: lessons from genetic association studies

Chiappelli, M., Tumini, E., Porcellini, E., & Licastro, F. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1327 · Cited by 10

Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study

Paroni, G., Lauriola, M., Andrea, F., D’Onofrio, G., Ciccone, F., Paris, F., Cascavilla, L., Urbano, M., Gravina, C., Copetti, M., et al. (2016) · Aging and Disease · doi:10.14336/ad.2015.1124 · Cited by 9

Design, current states, and challenges of nanomaterials in anti-neuroinflammation: A perspective on Alzheimer’s disease

Hong, X., Chen, T., Liu, Y., Li, J., Huang, D., Ye, K., Liao, W., Wang, Y., Liu, M., & Luan, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102669 · Cited by 9

Astrocytes and Inflammatory Processes in Alzheimer’s Disease

Vallés, S. L., Burguet, F., Iradi, A., Aldasoro, M., Vila, J. M., Aldasoro, C., & Jorda, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88701 · Cited by 9

The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization

Osse, A. M. L., Kinney, J. W., & Cummings, J. L. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70050 · Cited by 7

Effect of total flavonoids of Dracocephalum moldavica L . On neuroinflammation in Alzheimer's disease model amyloid-β (Aβ1-42)-peptide-induced astrocyte activation

Ren, W., Yan, X.-S., Fan, J.-C., Huo, D.-S., Wang, X., Jia, J., & Yang, Z.-J. (2024) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2336570 · Cited by 7

Subventricular zone neural progenitors reverse TNF-alpha effects in cortical neurons

Morini, R., Ghirardini, E., Butti, E., Verderio, C., Martino, G., & Matteoli, M. (2015) · Stem cell research & therapeutics · doi:10.1186/s13287-015-0158-2 · Cited by 6

William John Adie (1886-1935)

Pearce, J. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020321 · Cited by 7

Effect of Endurance Exercise Training and Gallic Acid on Tumor Necrosis Factor-α in an Animal Model of Alzheimer’s Disease

Bazyar, Y., Rafiei, S., Hosseini, A., & Edalatmanesh, M. A. (2015) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.3.3.21 · Cited by 7

The influence of tumour necrosis factor- α (TNF-α) on amyloid-β (Aβ)-degrading enzymes in vitro.

Culpan, D., Palmer, J. C., Miners, J. S., Love, S., & Kehoe, P. G. (2011) · PubMed Central · Cited by 7

Amyloid Beta, TNFα and FAIM-L; Approaching New Therapeutic Strategies for AD

Carriba, P., & Comella, J. X. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00276 · Cited by 7

What Have We Learned from the Tau Hypothesis?

Maccioni, R. B., Farias, G. A., Rojo, L. E., Sekler, M. A., & Kuljiš, R. O. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_5 · Cited by 7

Inflammation Friend or Foe?

Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00007-0 · Cited by 8

Neuroinflammation in Alzheimer's, Parkinson's and Huntington's Diseases

Sastre, M., Katsouri, L., Birch, A. M., Renziehausen, A., Dexter, D. T., Crichton, R. R., & Ward, R. J. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch6 · Cited by 6

Association between dementia risk and ulcerative colitis, with and without colectomy: a Swedish population-based register study

Garcia‐Argibay, M., Hiyoshi, A., & Montgomery, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074110 · Cited by 5

Modeling Sympathetic Hyperactivity in Alzheimer’s Related Bone Loss

Culibrk, R. A., Arabiyat, A. S., DeKalb, C. A., & Hahn, M. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215007 · Cited by 5

Processo Inflamatório e Neuroimunomodulação na Doença de Alzheimer

Rocha, N. P., Martins, L. D. C. A., Teixeira, A. L., & Reis, H. J. (2001) · Revista Neurociências · doi:10.34024/rnc.2011.v19.8385 · Cited by 24

Cytokines and Brain

Kielian, T., & Drew, P. D. (2005) · Humana Press eBooks · doi:10.1385/1-59259-905-2:041 · Cited by 4

Immunodepressed Status of Mice after Bulbectomy

Novoselova, E. G., Бобкова, Н. В., Glushkova, O. V., Sinotova, O. A., Ogay, V. B., Medvinskaya, N. I., & Samokhin, A. N. (2004) · Biology Bulletin · doi:10.1023/b:bibu.0000049734.07925.d8 · Cited by 4

Reasonable neuropsychological battery to identify mild cognitive impairment

Zhao, S., Liu, G., Shen, Y., & Zhao, Y. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.028 · Cited by 3

Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.

Farvadi, F., Hashemi, F., Amini, A., Vakilinezhad, M. A., & Raee, M. J. (2023) · PubMed Central · doi:10.22088/ijmcm.bums.12.2.172 · Cited by 3

Cytokines and Chemokines

Huang, Y., Erdmann, N. B., Hexum, T. D., & Zheng, J. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_15 · Cited by 3

The Immune State of Bulbectomized Mice

Novoselova, E. G., Бобкова, Н. В., Sinotova, O. A., Ogay, V. B., Glushkova, O. V., Medvinskaya, N. I., & Samokhin, A. N. (2003) · Doklady Biological Sciences · doi:10.1023/b:dobs.0000010308.59629.c0 · Cited by 3

Vascular Dementia

Jefferson, A. L., Gentile, A. M., & Kahlon, R. S. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch2 · Cited by 3

TNF-α induces type I IFN signalling to suppress neurogenesis and recruit T cells

Nissen, T. A. D., Baig, A., Farmand, S., Rock, D. T., Shibu, S., Lee, H., O'Neill, L. A., Houghton, V., John, S., Klavinskis, L. S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74104-x · Cited by 2

Efficacy and Safety of Stem Cell Therapy in Alzheimer's Disease: A Review

Arora, D., Gupta, D., Deeksha, Taneja, Y., & Dhingra, A. K. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x267673231120061600 · Cited by 2

Dementia: The Significance of Cerebral Metabolic Disturbances in Alzheimer's Disease. Relation to Parkinson's Disease

Hoyer, S., & Frölich, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_12 · Cited by 2

Cerebrospinal fluid biomarkers for neurodegenerative disorders

Videira, R. M. A. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2

Cellular and molecular mechanisms of Alzheimer’s disease inflammation

Peery, H. E., Strohmeyer, R., & Rogers, J. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_1 · Cited by 2

Level of Expression of BDNF and TNF-Alpha in the Somatosensory Cortex and its Effect on Social Interaction in Autism Model Rats Induced by Valproic Acid

Rezaei, E., & Biology, P. C. I. A. (2020) · SRPH Journal of Fundamental Sciences and Technology · doi:10.29252/sjfst.2.1.1 · Cited by 2

Decline of Immune Responsiveness: A Pathogenetic Factor in Alzheimer’s Disease?

Richartz-Salzburger, E., & Koehler, N. K. U. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_61 · Cited by 2

Diagnostic Value of Inflammatory Biomarkers in Differentiating Vascular Dementia From Alzheimer's Disease: A Systematic Review and Meta‐Analysis

Ling, Y., Sun, J., Hu, L., Zhao, M., Chen, J., & Zheng, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.71341 · Cited by 1

Microbiota–Gut–Brain Axis: An Integrative Overview of Communication Pathways

Martínez‐Porchas, M., Medina‐Félix, D., Olivas-Bernal, C. A., Guirado-Flores, J. S. O., Vargas‐Albores, F., Porchas‐Quijada, M., & Garibay-Valdéz, E. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/8142006 · Cited by 1

The Role of Insulin Resistance in Age-Related Cognitive Decline and Dementia

Watson, G. S., & Craft, S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_18 · Cited by 1

Biomarkers in vascular dementia

Wallin, A., & Pirttilä, T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575976.008 · Cited by 1

Novel Somatostatin Receptor Subtype‐4 Agonist Mitigates Microglia Inflammatory Activation

Silwal, A., Mobayen, S., Crider, A. M., Neumann, W. L., House, A., Umbaugh, D. S., Bhandari, S., Sandoval, K. E., & WITT, K. A. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.501.3 · Cited by 1

Alzheimer’s Disease

Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1

Cytokines and Chemokines

Huang, Y., & Zheng, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_17 · Cited by 1

Central Nervous System Inflammation and Cholesterol Metabolism Alterations in the Pathogenesis of Alzheimer’s Disease and Their Diagnostic and Therapeutic Implications

Rojo, L. E., Fernández, J. A., Jiménez, J. M., Maccioni, A. A., Sekler, A., Kuljiš, R. O., & Maccioni, R. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_11 · Cited by 1

Omega-3 fatty acid treatment in mild to moderate Alzheimer's disease : Results from the OmegAD study

Freund‐Levi, Y. (2008) · Figshare · Cited by 1

White matter lesions and soluble interleukin-1 receptor type II in CSF from demented and non-demented subjects

Bronge, L. H., Wahlund, L., Brauner, A., Basun, H., & Garlind, A. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00025-6 · Cited by 1

Alzheimer’s disease: from pathogenesis to novel therapeutic approaches

Scarpini, E. A., & Galimberti, D. (2009) · Therapy · doi:10.2217/14750708.6.2.259 · Cited by 1

Blood-Brain Barrier Permeability and Inflammation in Cerebral Small Vessel Disease

Walsh, J. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.50869 · Cited by 2

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

Tarkowski, E., Liljeroth, A.-M., Minthon, L., Tarkowski, A., Wallin, A., & Blennow, K. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00088-1 · Cited by 219

Intracerebral production of tumour necrosis factor-α in Alzheimer disease and vascular dementia

Tarkowski, E., Blennow, K., Wallin, A., & Tarkowski, A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)91366-2 · Cited by 4

Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia

Tarkowski, E., Wallin, A., Regland, B., Blennow, K., & Tarkowski, A. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.103003166.x · Cited by 91

Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia.

Cacabelos, R., Alvarez, X. A., Franco-Maside, A., Fernández‐Novoa, L., & Caamaño, J. C. (1994) · PubMed · Cited by 69

Amyloid-β reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFα from neuronal protection to death

Carriba, P., Jiménez, S., Navarro, V., Moreno‐González, I., Barneda‐Zahonero, B., Moubarak, R. S., López‐Soriano, J., Gutiérrez, A., Vitórica, J., & Comella, J. X. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.6 · Cited by 40